Remote or rural residence not associated with increased time to kidney transplantation

NewsGuard 100/100 Score

Contrary to what may be a common perception, researchers found no evidence that the likelihood of kidney transplantation is lower among remote- or rural-dwelling patients treated for kidney failure in the United States, according to a study in the April 22/29 issue of JAMA, the Journal of the American Medical Association.

Kidney transplantation is a life-saving medical procedure for which the demand far exceeds the supply of transplantable organs. A recent study suggested that rural location of residence within the United States was associated with lower rates of solid organ transplantation compared with those living in urban areas, a finding that is consistent with other work showing that rural dwellers have reduced access to health services, which raises the possibility that current organ allocation schemes may discriminate against people living farther away from transplant centers, according to background information in the article.

Marcello Tonelli, M.D., S.M., of the University of Alberta, Edmonton, and colleagues examined the association between distance from the closest transplant center and time to placement on the kidney transplantation waiting list or time to kidney transplantation. "Because the mandatory pretransplantation medical evaluation is more likely to be available in major medical centers, we hypothesized that people residing further from the nearest transplant center would be less likely to undergo transplantation," the authors write. The study included 699,751 adult patients with kidney failure who had initiated renal replacement in the United States between 1995 and 2007 and were on a prospective mandatory registry list.

During median (midpoint) follow-up of 2.0 years, 122,785 (17.5 percent) patients received a kidney transplant. Median distance to the closest transplant center was 15 miles. Participants were classified into distance categories by miles from a transplant center with 0-15 miles serving as the referent category.

"In contrast to our a priori hypotheses, we found that the likelihood of receiving a kidney transplant from a deceased or living donor among patients living farther away was similar to or greater than those residing within 15 miles of kidney transplant centers. Similarly, and again in contrast to our hypotheses, the adjusted likelihood of kidney transplantation was slightly lower among rural dwellers."

The authors add that the findings were independent of demographic factors, co-existing illnesses and measured socioeconomic characteristics.

"Although unexpected, our findings are encouraging because determining eligibility for kidney transplantation is a logistically challenging process that requires sequential diagnostic tests and encounters with health care clinicians. The finding that time to transplantation is similar or even shorter among remote- and rural-dwelling patients with kidney failure suggests that disparities in access for remote- and rural-dwellers with other diseases could be reduced or eliminated," the researchers write.

"These data suggest that efforts to improve equitable access to transplantation should not focus on populations defined solely by residence location."

http://jama.ama-assn.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gene therapy and glycoside drugs offer new hope for polycystic kidney disease treatment